As of November 16, 2021, the company has 14,491,171 issued shares with a nominal value of NIS 0.01 each (Corresponding to 14,491,171 voting rights)
As of November 16, 2021, SHL was aware of the following shareholders with more than 3% of all voting rights in the company:
Including Treasury Shares
Excluding Treasury Shares %
Cai Mengke and Shen Kun
|More Provident Funds||894,332|
|Value Base Group||837,865|
|Sphera Funds Management Ltd.||596,000|
|Danbar Finance Ltd.||540,000|
The above table of Significant Shareholders reflects both actual holdings as of November 16, 2021, after deducting from the total number of shares outstanding 14,834 Ordinary Shares held by SHL, and actual holdings as of November 16, 2021 calculated including ordinary shares held by SHL, all as indicated above, but does not reflect holdings on a fully diluted basis. All in accordance with notifications received by the Company from its shareholders as of November 16, 2021.
Disclosure of Management Transactions
SHL Telemedicine has to report to SIX Swiss Exchange all transactions of SHL shares and options made by the Board of Directors and the executive management. The disclosure of management transactions is intended as a means of furthering the supply of information to investors. Such disclosure provides investors with additional qualitative insight with regard to their investment decision.
Click here for the Management Transaction disclosure of SHL Telemedicine on the SIX-Platform.